These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3197250)
1. [Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol]. Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):548-54. PubMed ID: 3197250 [TBL] [Abstract][Full Text] [Related]
2. [Complement: a sign of infestation of sheep by Trypanosoma brucei brucei in an experimental model: its evolution following treatment]. Bouteille B; Darde ML; Monteil J; Pestre-Alexandre M Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):522-31. PubMed ID: 3197249 [TBL] [Abstract][Full Text] [Related]
3. The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis. Jennings FW Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):595-607. PubMed ID: 2848638 [TBL] [Abstract][Full Text] [Related]
4. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study. Poltera AA; Hochmann A; Lambert PH Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886 [TBL] [Abstract][Full Text] [Related]
5. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo]. Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of experimental trypanosomiasis of sheep caused by Trypanosoma brucei brucei: efficacy of Ro 15-0216 (a 2-nitroimidazole derivative)]. Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):616-22. PubMed ID: 3197255 [TBL] [Abstract][Full Text] [Related]
7. The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol. Jennings FW; Atouguia JM; Murray M Acta Trop; 1996 Oct; 62(2):83-9. PubMed ID: 8988309 [TBL] [Abstract][Full Text] [Related]
8. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469 [TBL] [Abstract][Full Text] [Related]
9. [EEG and treatment with Arsobal in human African trypanosomiasis]. Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245 [TBL] [Abstract][Full Text] [Related]
10. Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment. Veeken HJ; Ebeling MC; Dolmans WM Trop Geogr Med; 1989 Apr; 41(2):113-7. PubMed ID: 2763355 [TBL] [Abstract][Full Text] [Related]
11. Suggested dosage rates of melarsoprol in the treatment of mice experimentally infected with Trypanosoma brucei gambiense. Mbati PA; Hirumi K; Inoue N; Situakibanza NH; Hirumi H Onderstepoort J Vet Res; 2000 Mar; 67(1):71-4. PubMed ID: 10843325 [TBL] [Abstract][Full Text] [Related]
12. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome]. Pialoux G; Kernbaum S; Vachon F Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251 [TBL] [Abstract][Full Text] [Related]
13. Trypanosoma brucei rhodesiense: effect of immunosuppression on the efficacy of melarsoprol treatment of infected mice. Frommel TO Exp Parasitol; 1988 Dec; 67(2):364-6. PubMed ID: 3191962 [No Abstract] [Full Text] [Related]
14. [Trial of pentamidine in the treatment of trypanosomiasis of sheep inoculated with Trypanosoma brucei brucei]. Nicolas JA; Bosgiraud C; Dubost G; Amevigbe M; Pestre-Alexandre M; Bouteille B; Darde ML; Vallat JM; Dumas M Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):623-5. PubMed ID: 3197257 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of human African trypanosomiasis]. Dumas M; Breton JC; Pestre-Alexandre M; Nicolas JA; Catanzano G Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):622-7. PubMed ID: 6673855 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of three regimens of melarsoprol in the treatment of Trypanosoma brucei gambiense trypanosomiasis. Pépin J; Mpia B Trans R Soc Trop Med Hyg; 2006 May; 100(5):437-41. PubMed ID: 16483622 [TBL] [Abstract][Full Text] [Related]
17. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility. Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658 [TBL] [Abstract][Full Text] [Related]
18. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei]. Bouteille B; Darde ML; Pestre-Alexandre M Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy, relapses and CNS in experimental African trypanosomiasis. Poltera AA Contrib Microbiol Immunol; 1983; 7():155-64. PubMed ID: 6825437 [No Abstract] [Full Text] [Related]
20. Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis. Rodgers J; Jones A; Gibaud S; Bradley B; McCabe C; Barrett MP; Gettinby G; Kennedy PG PLoS Negl Trop Dis; 2011 Sep; 5(9):e1308. PubMed ID: 21909447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]